ReviewExperimental & molecular medicine2023

Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases.

Yelin Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.